| Preliminary Program subject to change | |||||||||
| T5003 Strategies in Biopharmaceutical Scale-up & Pilot Plants | |||||||||
| Overview | While reducing the timelines to market is still a challenge, adopting efficient scale-up and technology transfer strategies in the biopharmaceutical industry is critical. In this race to commercialize new technology, or to improve existing technology, it is widely accepted that pilot plants play a key role in the overall process development scheme. Therefore, this session is particularly interested in topics that include, but are not limited to, scale-up approaches and troubleshooting for upstream and downstream processes, unique technology transfer strategies, design and operation of pilot plants, case studies on processes that are scaled-up in pilot plants that demonstrate a unique team approach and delivery under aggressive timelines and budget limitations. | ||||||||
| Primary Sponsor | Topical 5: Pilot Plant Design and Optimization (T5) | ||||||||
| Co-Sponsor(s) | Pilot Plants (12b), Pharmaceuticals (See also Topical 2) (15b), Topical 2: Discover, Development and Delivery of Medicines (T2) | ||||||||
ChairNihal TugcuResearch Fellow BioPurification Development Merck and Co., Inc. RY805S-100 126 E. Lincoln Ave. PO Box 2000 Rahway, NJ 07065 Phone Number: 732-594-0495 Email: nihal_tugcu@merck.com
CoChairJeanette BeardProject Engineer Zeton Inc. 740 Oval Court Burlington, ON L7L 6A9 Canada Phone Number: (905) 632-3123 x237 Fax Number: (905) 632-0301 Email: jbeard@zeton.com | |||||||||
| |||||||||